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 Highlights 
 Inhibitory control is impaired in obese adults and children compared to controls 
 This impairment is independent from the presence of binge eating disorder 
 Reduced prefrontal cortex activity affects inhibitory control and BMI 
 
 
  
 Abstract 
The ability to exercise appropriate inhibitory control is critical in the regulation of body weight, but the 
exact mechanisms are not known. In this systematic review, we identified 37 studies that used specific 
neuropsychological tasks relevant to inhibitory control performance in obese participants with and 
without binge eating disorder (BED). We performed a meta-analysis of the studies that used the stop 
signal task (N=8). We further examined studies on the delay discounting task, the go/no-go task and the 
Stroop task in a narrative review. We found that inhibitory control is significantly impaired in obese 
adults and children compared to individuals with body weight within a healthy range (Standardized 
Mean Difference (SMD): 0.30; CI= 0.00, 0.59, p=0.007). The presence of BED in obese individuals did not 
impact on task performance (SMD: 0.05; CI: -0.22, 0.32, p=0.419). Neuroimaging studies in obesity 
suggest that lower prefrontal cortex activity affects inhibitory control and BMI. In summary, impairment 
in inhibitory control is a critical feature associated with obesity and a potential target for clinical 
interventions.  
Keywords: inhibitory control, stop signal, go/nogo, prefrontal cortex, obesity, binge eating 
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 1.0 INTRODUCTION 
Obesity is currently considered a global pandemic affecting more than one third of U.S. adults 
(Ogden et al., 2014; Swinburn et al., 2011) and 13% worldwide, a rate that has doubled since 
1980 (World Health Organization, 2015). It is related to increased overall mortality for 
Alzheimer's disease  (Misiak et al., 2012), cancer (Vucenik and Stains, 2012) and heart disease 
(Lu et al., 2014). Abdominal obesity is also associated with a substantial disease burden with 
increased risk of type 2 diabetes mellitus and cardiovascular disease (Alberti et al., 2005; Lakka 
et al., 2002; Lorenzo et al., 2003). Available treatments are often ineffective in modifying the 
lifestyle and eating behavior that lead to obesity (Fabricatore and Wadden, 2006), therefore the 
development of innovative treatments that can impact on these domains is now a public health 
priority.  
Binge Eating Disorder (BED) is an eating disorder characterized by recurrent episodes of 
excessive food consumption accompanied by a sense of loss of control (American Psychiatric 
Association, 2013). It is the most prevalent type of eating disorder (Hudson et al., 2007) and it 
affects up to 25% of obese  individuals seeking weight-loss treatment (Pull, 2004). Binge 
episodes have been proposed to be triggered by a breakdown of self-regulation caused by 
sudden increases in negative affect and tension (Munsch et al., 2012). 
Impairment in executive function is consistently found  in several neuropsychiatric syndromes 
(Etkin et al., 2013), including eating disorders (Van den Eynde et al., 2011). Inhibitory control, 
one of the fundamental components of executive function, can be operationalized as the 
overriding of a planned or already initiated action (e.g. responding to a stimulus, or seeking a 
reward) (Bari and Robbins, 2013). When experiencing strong impulses or urges to eat, a lack of 
inhibitory control may cause impulsive eating and lead to obesity (Appelhans, 2009). Inhibitory 
control is experimentally assessed with standardized and validated tests, such as the go/no-go 
task, stop-signal task (SST), Stroop task and delay discounting task (Chambers et al., 2009). 
These tasks are thought to measure different facets of inhibitory control. The go-no/go task and 
the SST are considered typical measures of response inhibition (Chambers et al., 2009). In the 
go-no/go task, participants are instructed to respond as quickly as possible (e.g. pressing a 
button) when a frequent go signal appears, but must inhibit the response when an infrequent 
stop signal occurs. Inhibitory control performance is assessed based on the percentage of 
responses to stop signals (errors). In the SST, the go signal is interrupted in some trials by a stop 
signal presented after it. Participants are instructed to cancel the go response when they are 
shown the stop signal. Typically, the more the presentation of the stop signal is delayed, the 
more difficult it is for the participant to withhold the response. This situation is usually 
interpreted with the race model (Logan and Cowan, 1984): whether a participant manages to 
withhold the response depends on the result of the competition of two independent processes: 
go and stop. The stop trial won’t be successful (resulting in a failure to inhibit the response) 
when the go process is completed before the stop process. Traditionally, the most used 
outcome measure in the SST is the stop signal reaction time (SSRT). The SSRT is calculated 
subtracting the stop signal delay (the delay between go and stop signal that allows correct 
inhibition on approximately 50% of the stop trials) from the mean reaction time (mean reaction 
time to a go trial). Shorter the SSRT better the inhibitory performance. The Stroop task is also 
used as a measure of response inhibition (Potenza et al., 2003), although it has been suggested 
that other processes such as conflict resolution and response selection could also be involved 
(Chambers et al., 2009). In a basic version, the Stroop task is comprised of three conditions. In 
the reading condition, the participant reads words written in black ink. In the color naming 
condition, the participant has to name the colors of a series of colored squares. Finally, in the 
inhibition condition, the participant is presented a series of words written in different colors 
and is asked to name which color the words are written in. The words are printed in an ink that 
is incongruent with the word (for example, the word ‘red’ is written in green ink). The 
participant needs to process task-relevant color information (ink) and inhibit prepotent 
processing of conflicting task-irrelevant information (word). Performance is measured with 
completion time (longer response time=worse inhibitory control). In the delay discounting task, 
poor inhibitory control is defined as the tendency to choose immediate, smaller rewards over 
larger but postponed ones in a series of trials (steep discounting of value as a function of time). 
The delay discounting task has been suggested to recruit more affectively charged cognitive 
processes compared to the previously described response inhibition paradigms (Bari and 
Robbins, 2013). Inhibitory control as measured in the above  laboratory tests is thought to be a 
relatively stable and general trait which affects several specific domains/contexts (e.g. food 
intake, smoking or substance abuse)(Bari and Robbins, 2013). 
The relationship between inhibitory control, obesity and binge eating has not been fully 
understood yet. In particular, it is not clear if inhibitory control processes are impaired in 
obesity in general or more specifically related to binge eating behavior. Since BED has been 
associated with high co-morbidity with other psychiatric disorders (Hudson et al., 2007; Kessler 
et al., 2013) and medical disorders (Javaras et al., 2008), it is important to study the specific 
neurocognitive mechanisms that characterize it, distinguishing them from those that underlie 
obesity without BED. Schag et al, in a narrative review, reported that obese participants with 
BED had increased scores in self-report measures of food-related impulsivity compared with 
normal weight controls and that impulsivity was more pronounced in BED individuals compared 
to obese participants without BED (Schag et al., 2013). Other studies found lower inhibitory 
control performance (as measured by SST) to predict the outcome of a weight loss program in 
obese children and adolescents (Kulendran et al., 2014; Nederkoorn et al., 2007). Nederkoorn 
and colleagues specifically assessed binge eating: only 2 children of the 26 who participated in the study 
had binge episodes. The above findings suggest that dysfunctional inhibitory control could be an 
underlying cognitive deficit in people who gain weight regardless of binge eating patterns.  A 
systematic assessment of the available literature on inhibitory control tasks in obese individuals 
with and without BED appears to be indicated to gain a better understanding of this issue. 
Several lines of clinical evidence suggest that inhibitory control of eating behavior is regulated 
by the neural circuitry involving the frontal cortex (Knoch and Fehr, 2007; Szczepanski and 
Knight, 2014). First, frontal lobe dysfunctions have been shown to be associated with altered 
eating behaviors (Alonso-Alonso and Pascual-Leone, 2007). Hyperphagia as a clinical sign has 
been reported in neurologic syndromes that are characterized by frontal lobe impairment such 
as fronto-temporal dementia (Ikeda et al., 2002; Piguet, 2011; Whitwell et al., 2007), Klein-Levin 
syndrome (Landtblom et al., 2002) and the “Gourmand syndrome” (Regard and Landis, 1997). 
Second, hyperphagia and overweight were common in patients who underwent frontal 
leucotomy, a surgical procedure that disconnected the frontal lobes from the rest of the brain 
in an attempt to treat severe mental illness (Freeman and Watts, 1950). Third, frontal lobe 
dysfunction has been suggested to be the cause of altered eating behavior in Prader-Willi 
syndrome, a genetic disorder associated with developmental delay, obesity and hyperphagia 
(Ogura et al., 2008). A recent neuroimaging study comparing obese participants with Prader-
Willi syndrome to obese participants without the syndrome found post-meal hypoactivation of 
the dorsolateral prefrontal cortex (PFC) during response to food vs non-food images (a measure 
of inhibitory control)(Holsen et al., 2012). Finally, symptoms related to dysfunction of the 
frontal cortex have also been reported in obesity with BED: for instance, participants with BED 
showed higher scores in the Frontal Systems Behavior Scale, a measure of neurobehavioral 
traits associated with the PFC (Boeka and Lokken, 2011). 
Functional neuroimaging studies are important to understand the neuroanatomical and 
functional mechanisms of inhibitory control deficits in obesity and binge eating, and to devise 
cognitive and brain targets for novel neuromodulatory techniques (Alonso-Alonso, 2013). 
The aims of this systematic review and meta-analysis are twofold: a) to evaluate the presence 
of alterations in inhibitory control performance in obese participants with and without BED; 
and b) to assess neural correlates of inhibitory control performance in obese participants 
compared to normal weight controls. Accordingly, the proposed systematic review will address 
the following questions:  
1. Do obese participants have impairments in inhibitory control indexed by performance in 
specific neurocognitive tests compared to normal weight controls? 
2. Do obese participants with binge eating disorder have more severe impairments in 
inhibitory control compared to obese participants without the disorder? 
3. Is neural activation in the prefrontal cortex measured by neuroimaging techniques 
altered in obese participants compared to normal weight controls during a standard 
inhibitory control task? 
We hypothesize that inhibitory control is impaired in obese participants compared to normal 
weight controls and in obese participants with BED compared to obese controls; we also expect 
to find reduced PFC activation during inhibitory control tasks in obese participants compared to 
controls. 
 
2.0 METHODS  
2.1 Search strategy 
The review process was conducted according to the principles of the PRISMA-Statement 
(Liberati et al., 2009; Moher et al., 2009; Shamseer et al., 2015). Searches were conducted up to 
April 2015; all relevant articles published before the end of April 2015 were considered for 
inclusion. We did not establish any restrictions on publication date. The PRISMA flow chart for 
study inclusion is reported in Figure 1. Entire PubMed, EMBASE and PsychInfo were searched 
for published experimental studies examining group differences in inhibitory control between 
obese and control participants and between binge eating obese and non-binge eating obese 
participants. Reference lists of relevant articles were also searched. Search terms were 
“obesity” AND “go/no-go”; “obesity” AND “stop-signal”; “obesity” AND “delay discounting”; 
“obesity” AND “Stroop”; “obesity” AND “inhibitory control”. Search terms that included the 
Medical Subject Headings (MeSH) terms were based on the following path: (obesity [MeSH] OR 
overweight *MeSH+ OR “binge eating disorder” *MeSH+ OR hyperphagia *MeSH+ OR "body mass 
index" *MeSH+ OR “binge eating” *Title/Abstract+) AND (“inhibition(psychology)"*mesh+ OR 
“stop-signal” *Title/Abstract+ OR “go/no-go” *Title/Abstract+ OR “behavioral inhibition” 
*Title/Abstract+ OR “response inhibition” OR “delay discounting” *Title/Abstract+ OR “self-
regulation” *Title/Abstract+ OR “self-control” *Title/Abstract+). 
 
2.2 Eligibility Criteria 
The eligibility criteria followed the modified PICOS-criteria (Liberati et al., 2009) and aimed to 
select overweight/obese individuals of any age with or without BED individuals. Overweight is 
defined as BMI between 25 and 30; obesity is defined as body mass index (BMI)>30. Case-
control studies comparing obese participants and matched participants with normal weight or 
obese participants with and obese participants without binge eating behaviors were 
considered. Studies featuring participants with other psychiatric or somatic syndromes capable 
of affecting weight or eating behavior, such as Prader-Willi syndrome, were excluded. Outcome 
measures eligible for inclusion were neurocognitive tasks assessing inhibitory control. Given the 
stated focus of the review on neurocognitive tests and neuroimaging, findings regarding other 
modalities (e.g. EEG) were not considered for discussion. Qualitative studies that used 
questionnaires were excluded. An essential element for inclusion was that studies should have 
clear descriptions of methods used. This search strategy resulted in three categories of studies: 
1) adults with obesity and BED; 2) children and adolescents with obesity/overweight (age 6 to 
17 years); 3) neuroimaging studies on inhibitory control paradigms in obese participants with 
and without BED. 
 
2.3 Study selection and data collection 
Study eligibility was assessed following the defined eligibility criteria as shown in the flowchart 
in Figure 1. All results were screened by scanning article titles and abstracts. Duplicate 
publications were excluded from further analysis.  
 
2.4 Data extraction and quality assessment 
Data extraction was operationalized to identify: 1) demographic and clinical characteristics of 
the study population (age, BMI, male to female ratio); 2) diagnosis (obesity with or without 
BED); 3) type of neurocognitive test used; 4) description of the results. 
Given the lack of standardized criteria for the assessment of neuropsychological studies, we 
developed a standardized checklist for quality assessment and the identification of risk of bias. 
The checklist was based on the Newcastle-Ottawa scale (NOS: 
www.ohri.ca/programs/clinical_epidemiology/oxford.htm). We considered the quality items for 
the first two domains (`selection` and `comparability`), given that the third domain of the scale 
(`exposure`) was not pertinent to the studies we considered. Ratings were summed up to a 
total score with a maximum value of 8: 6 points for sample selection and assessment of 
potential for selection biases; 2 points for comparability and controlling for confounding 
factors. Quality levels of evidence were defined as high (7-8 points); medium (4-6 points) and 
low (1-3 points). 
 
2.5 Quantitative data synthesis, additional analyses  
Statistical analysis as previously described (Arnone et al., 2012, 2009; Selvaraj et al., 2014) was 
conducted using STATA 11.0 (Stata Corp, College Station, Texas) supplemented by ‘Metan’ 
software downloadable from the Centre for Statistics in Medicine, Oxford, UK. Standardised 
mean differences were calculated using Cohen’s d statistic: 
Cohen’s d = 
     
   
 
Where   and    are the mean values from the first and second groups, respectively and     
is the pooled standard deviation estimated from both groups: 
 
SDp = √
(    )   
   (    )    
 
(        )
 
Where    and     are the mean and standard deviation of the ‘ith’ group. Standardised effect 
sizes were then combined using the inverse variance method. The variance of Cohen’s d is 
estimated as: 
SD(d) = √
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 Where   is the total sample size for the study, d is Cohen’s d and   and    are as defined 
above. Random effects analyses (DerSimonian and Laird, 1986) were used throughout to weight 
each study. The presence of heterogeneity was tested using the Q-test and its magnitude 
estimated using I2, which can be interpreted as the proportion of effect size variance due to 
heterogeneity (Higgins et al., 2003). When the Q-test was significant, we used a Galbraith plot 
to identify those studies contributing the greatest amount to that heterogeneity, in order to 
investigate potential causes. Publication bias, which describes the tendency of small studies to 
report large effect sizes, was examined using the Egger’s test (Egger et al., 1997). The 
significance level was set at p < 0.05. 
Replicability of the findings was tested by means of sensitivity analyses, which excluded one 
study at the time to ascertain whether measured effect sizes were influenced by any specific 
dataset. To further investigate causes for heterogeneity, meta-regression analyses were 
performed for the following variables: age, sex, BMI, presence of comorbidity, year of 
publication. The STATA program "metareg.ado" was used throughout with REML (restricted 
maximum likelihood) method as the default algorithm (Thompson and Sharp, 1999). 
 
3.0 RESULTS 
3.1 Study selection  
Searches resulted in 1793 eligible studies of which 37 met inclusion criteria. Figure 1 provides a 
flow chart with reasons for exclusion and Tables 1, 2 and 3 summarize the details of the studies 
included. Inhibitory control has shown significant differences in performance between children 
and young adults (Williams et al., 1999) likely as a consequence of different developmental 
stages. Therefore, the studies reporting on adults (Table 1) and children and adolescents (Table 
2) will be discussed separately. 
 
3.2 Inhibitory control in adults 
Overall, 20 studies that investigated differences on inhibitory control performance in groups of 
adults were included (see Figure 1 for details). The studies included group comparisons 
between obese participants and individuals with normal weight (N=15) and between obese 
participants with BED and without BED (N=8) (Table 1). The quality of most studies assessed on 
the basis of sample selection, thoroughness of reporting and avoiding biases, was scored 
“medium” for most studies (14 studies), “low” for one study, and “high” for five studies. See 
Table 1 for details of samples, tasks used and quality scores. The most represented task, used in 
approximately 35% of the studies (N=7) was the stop signal task (SST). Other tasks reported 
were delay discounting task, go/no-go task and Stroop task. A significant decrease in inhibitory 
response performance in any task was evident in obese individuals compared to lean controls in 
60% of the reports (N=9), while the remaining studies did not show a significant difference. 
Conversely, inhibitory control performance was found to be impaired in only 37% of studies on 
obese participants with BED compared to obese participants without BED (N=3). In one study 
(Mole et al., 2014) obese participants without BED showed higher stop signal response time, 
and therefore greater impairment in inhibitory control, compared to obese participants with  
BED.  
 
3.3 Meta-analyses 
The difference in neurocognitive tasks used did not allow us to include all available results in a 
quantitative meta-analysis (Table 1). However, it was possible to perform a meta-analysis of the 
six studies that used the SST task to study differences in inhibitory control performance 
between  obese participants and  normal weight controls (Bongers et al., 2014; Chamberlain et 
al., 2015; Grant et al., 2015; Hendrick et al., 2012; Mole et al., 2014; Nederkoorn et al., 2006), 
and of the three studies that compared obese participants with BED  to obese participants 
without BED. As shown in Figure 2, we measured a significant impairment in inhibitory control 
in the obese participants compared to controls, indexed by increases in SSRT, with a 
Standardized Mean Difference (SMD) = 0.30 (CI: 0.00, 0.59, p=0.007), in the absence of 
publication bias (p=0.37). The presence of significant heterogeneity (p<0.007) was not 
explained by the variables we considered in meta-regression analyses (all ps> 0.05). The analysis 
of the obese participants with BED and obese participants without BED groups (Figure 3)(Mole 
et al., 2014; Svaldi et al., 2014; Wu et al., 2013) indicated the absence of a significant difference 
between the two groups (SMD: 0.05; CI: -0.22,0.32, p=0.419) with no evidence of publication 
bias (p=0.89) or an excess of heterogeneity (p=0.89). 
Overall, the results of the studies suggest that obese participants without BED had decreased 
performance in inhibitory control tasks compared to normal weight controls (i.e., higher 
reaction times or steeper discounting), while the group comparisons between obese 
participants with BED and obese participants without BED were not significant.  
 
3.4 Inhibitory control in children and adolescents 
Ten studies comparing obese children with normal weight controls met inclusion criteria. The 
quality score was “medium”in 7 studies and “high” in three studies. The features of the studies 
are summarized in Table 2. The heterogeneity of the age ranges in the samples was notable, 
varying between 7 to 9 years (Kamijo et al., 2012; Nederkoorn et al., 2012) and 13 to 19 years 
(Fields et al., 2011). Since there are relevant age-related differences in inhibitory control, which 
reflect different developmental stages (Williams et al., 1999), we did not perform a meta-
analysis. All the studies included in this category found inhibitory control to be impaired in 
obese children compared to peers of the same age group.  
 
3.5 Neuroimaging studies of inhibitory control 
Given the paucity of neuroimaging studies on overweight/obese participants using inhibitory 
control paradigms, we decided to include all available neuroimaging studies that investigated 
the relationship between neural activation related to inhibitory control and BMI to provide a 
narrative review on neural circuitry involved in inhibitory control in obesity. The quality score 
was not applied here, since group comparison was not a requirement. Table 3 summarizes the 
features of the seven neuroimaging studies included and the findings. 
Inhibitory control-related activity in regions of the PFC such as the superior frontal gyrus, the 
middle frontal gyrus and inferior frontal gyrus have been found to correlate inversely with 
baseline BMI (Batterink et al., 2010; Hendrick et al., 2012) and with subsequent weight increase 
(Batterink et al., 2010; Kishinevsky et al., 2012; Weygandt et al., 2015, 2013). These findings 
have been summarized in Figure 4. Activation in other regions that are considered part of an 
extended inhibitory control network, such as parietal cortex, insula, cuneus, supplementary 
motor area (Bari and Robbins, 2013; Chambers et al., 2009; Ghahremani et al., 2015; Luijten et 
al., 2014) were also found to correlate inversely with BMI (Hendrick et al., 2012). 
Two studies investigating group differences between obese participants with BED and obese 
participants without BED found reduced bilateral activation of the PFC during inhibitory control 
tasks in obese participants with BED (Balodis et al., 2013; Hege et al., 2014). 
 
4.0 DISCUSSION 
Our main findings are that there is a decrease in inhibitory control performance in adult obese 
participants without BED compared to controls and in obese children and adolescents 
compared to controls. There was no significant difference in inhibitory performance in obese 
participants with and without BED. Functional neuroimaging of neural activation during 
inhibitory control tasks in obese participants with BED compared to obese participants without 
BED reveal a consistent pattern of reduced activation in the PFC. Also, increased BMI is related 
to a decrease in inhibitory-control related activity in a network where the PFC is the key node 
(Batterink et al., 2010; Kishinevsky et al., 2012; Weygandt et al., 2015, 2013). 
 4.1 Behavioral investigations 
The available studies with inhibitory control tasks and the meta-analysis of the studies that 
used the stop-signal test (SST), indicate the presence of inhibitory control deficits in obese 
participants without BED compared to controls in both adults and children. A recent narrative 
review which considered selectively the role SST in eating disorders and obesity also concludes 
that obese individuals may show impaired inhibitory control, although they point out that the 
results may differ depending on which stimuli are used (Bartholdy et al., 2016). The 
multidimensional nature of control inhibition and the discrepancy in results based on the 
technique used to measure this complex construct is also supported by a recent study 
suggesting a lack of association between BMI and response inhibition (Lawyer et al., 2015). 
However, our results of inhibitory control deficits in obese participants without BED compared 
to normal weight controls is consistent with longitudinal studies that found that worse 
inhibitory control performance is correlated with greater subsequent weight increase 
(Kulendran et al., 2014; Nederkoorn et al., 2007; Pauli-Pott et al., 2010; Weygandt et al., 2013), 
and was related to higher food intake in eating laboratory protocols (Appelhans et al., 2011). 
These results indicate that inhibitory control performance deficits may predict weight increase 
over time. It is likely that impairments in inhibitory control play a role in resisting the impulse to 
obtain tasty but unhealthy food, and in effectively downregulating the motivation to consume 
desirable food: both these functions have been shown to recruit the prefrontal cortex (Hare et 
al., 2009; Hollmann et al., 2012). 
Preliminary studies suggest that specific inhibitory control training can be effective in altering 
short-term eating behavior in controlled experimental conditions (Houben, 2011; Lawrence et 
al., 2015; van Koningsbruggen et al., 2014). In van Koningsbruggen et al. (2014), participants 
receiving two different interventions aimed at potentiating inhibitory control selected 
respectively 36% and 51% fewer sweets than control participants in a controlled laboratory 
environment. In a study by Lawrence et al. (2015), a group of participants who were trained to 
inhibit motor responses to pictures of food ate significantly less calories (-60 kcal; 95%CI=-1.51 
to -118.68 kcal), compared to participants that were trained to execute a response to food 
pictures in an ad-libitum snacking test.  Although large scale clinical studies are necessary for 
confirmation in this patient population, there are encouraging findings pointing to rapid 
plasticity in inhibition-related brain regions as a result of practice of inhibitory processes 
(reviewed in Chambers et al., 2009). These studies open up a therapeutic possibility that 
inhibitory control deficits can potentially be improved and sustained by specific neurocognitive 
training. 
The relationship between inhibitory control and binge eating is less clear. In the studies we 
examined, obese participants with BED do not seem to show a consistent impairment of 
inhibitory control compared to obese participants without BED. The meta-analysis considering 
only the studies that utilized the SST (n=3) does not show a significant difference between the 
groups (see Figure 3).  This could be due to small study bias (we were able to find only 7 such 
studies, only 3 utilized the SST and were included in the meta-analysis). However, there was no 
evidence of publication bias in the meta-analysis, nor any significant excess of heterogeneity. 
This result is consistent with recent reviews reporting no significant differences in inhibitory 
control in participants with eating disorders compared to controls (Bartholdy et al., 2016; Van 
den Eynde et al., 2011). However a recent study by Manasse and others suggests that the use 
of the Stop Signal Task might be sensitive to elucidating inhibitory deficits in obese individuals 
with binge eating features although not selective to specific stimuli type (Manasse et al., 2016). 
Recently, a psychostimulant (lisdexamfetamine) has been approved for the treatment of BED by 
the Food and Drug Administration. Lisdexamfetamine appears to result in weight decreases 
between 5.2% and 6.25% at 50 or 70 mg/day (Citrome, 2015). Psychostimulants are known to 
facilitate response inhibition by modulating PFC function (Solanto, 1998; Spencer et al., 2001). 
In addition, successful amelioration or remission of binge eating in participants with BED 
through treatment with antidepressants (Capasso et al., 2009; McElroy et al., 2012; Reas and 
Grilo, 2008) or psychosocial interventions (Wilson et al., 2010) have not resulted in significant 
weight loss. It is possible that lisdexamfetamine, through the modulation of prefrontal function, 
might lead to an additional improvement in inhibitory control and thus lead to weight loss. 
Prospective studies on weight changes with long-term treatment with active comparative 
treatments and evaluation of response inhibition function will be needed to clarify these 
mechanisms (McElroy et al., 2015).  
Schag and colleague’s review only considered behavioral tasks investigating food-related 
impulsivity (Schag et al., 2013), while we based our selection on standardized inhibitory control 
neurocognitive tasks. Our choice seems to be supported by the evidence for higher stop signal 
reaction time (SSRT) in obese participants without BED compared to controls, suggesting a 
general decrease in inhibitory function regardless of binge eating behavior. Another factor 
could be related to the broader domain of "impulsivity" that Schag and colleagues investigated, 
in contrast to our more focused investigation on inhibitory control. Inhibitory control can be 
measured by specific neurocognitive tasks and depends on the activity of the PFC, and it seems 
particularly well suited to offer mechanistic insights into the regulation of eating behavior. As 
noted by Appelhans (Appelhans, 2009), a better understanding of inhibitory control can help us 
understand why some individuals, after starting a diet, manage to achieve successful dietary 
restraint while some do not. The reward value of food is unlikely to be diminished by the 
conscious decision to initiate dietary restriction, therefore the key element that leads to 
success in a diet is to exert sufficient inhibitory control (Appelhans, 2009). The ability to exert 
this control in everyday situations like buying food, preparing it or eating it during a meal are 
likely to be the concrete behaviors that mediate the effect of neurocognitive deficits in 
inhibitory control on BMI, in a similar manner to how self-control to substance-related cues in 
the environment affects the ability to abstain from substances in substance abusers (Blume and 
Marlatt, 2009). 
 
4.2 Neuroimaging investigations 
Studies comparing brain activation during inhibitory control tasks found reduced activation in 
the PFC (inferior frontal gyrus, ventromedial prefrontal cortex, dorsolateral prefrontal cortex) in 
obese participants with BED compared to obese participants without BED (Balodis et al., 2013; 
Hege et al., 2014). More prospective studies that compare obese participants with BED to 
obese participants without BED are clearly needed to examine if abnormal prefrontal cortex 
activity is related to development of binge eating in obesity.  
The studies investigating correlations between activity in inhibitory control-related brain 
function in areas, such as the PFC (superior and middle frontal gyrus, orbitofrontal cortex) and 
the inferior parietal cortex, and both current and future BMI found consistent negative 
correlations. Figure 4 summarizes the localization of these regions in the brain. The PFC is 
considered the key region involved in self-regulation. It represents goals and the means to 
achieve them, and it allows us to modulate our responses to environmental stimuli by 
exercising top-down inhibitory control (Miller and Cohen, 2001). Impairments of PFC function 
have been associated with eating dyscontrol and weight gain in many lesion studies (Freeman 
and Watts, 1950; Ikeda et al., 2002; Landtblom et al., 2002; Piguet, 2011; Regard and Landis, 
1997; Whitwell et al., 2007), therefore the present results appear consistent with the well-
known role of the PFC. The PFC showed low baseline metabolic activity in obese participants in 
studies with positron emission tomography (PET)(Volkow et al., 2009) and single-photon 
emission computed tomography (SPECT)(Willeumier et al., 2011). PFC hypofunctionality in 
obesity has also been suggested to be associated with lower gray matter volumes (Yokum et al., 
2012). Other studies showed an increased PFC activity in successful dieters compared to 
controls in response to meal consumption (DelParigi et al., 2007). Also, less activation of the 
PFC in response to a meal in obese participants compared to controls (Le et al., 2007, 2006) 
suggest that reduced PFC function is responsible for a lack of inhibition of hedonic feeding in 
the obese participants (Appelhans, 2009). Our review indicates that standardized inhibitory 
control tasks index PFC activity and correlate with baseline BMI and future weight outcomes. 
This framework could offer a mechanistic model for brain-based treatments for eating behavior 
in obesity. Inhibitory control could be a target for stimulation treatments that modulate PFC 
function in obese patients (Alonso-Alonso, 2013). Innovative and personalized treatment 
strategies can be developed by establishing the specific type of obese participants who can 
benefit from neuromodulation treatments. 
 
4.3 Limitations 
Due to slight variations in the specific names of the tasks (e.g. stop signal task, go-stop task, 
stop task; delayed discounting task, temporal discounting task), some studies might have been 
missed in our search. However, we believe that our thorough search procedure should have 
addressed this possibility. The level of heterogeneity detected in the meta-analysis in the 
comparison between obese participants without BED and controls could not be explained with 
the variables that we included in the meta-regression. This might be caused by partial reporting 
of these variables or by other variables that we could not identify. In this regard, it is important 
to note that obese participants compared to controls were not screened for binge eating in 
some studies included in the meta-analysis (Bongers et al., 2014; Hendrick et al., 2012; 
Nederkoorn et al., 2006), which could be a source of heterogeneity. However, the finding of 
inhibitory control deficits in obese participants without BED compared to controls seems 
unlikely to be driven by the presence of obese participants with BED in the sample, given that 
the direct comparison between obese participants with BED and obese participants without 
BED does not show worse inhibitory performance in obese participants with BED. There are few 
studies that provide direct comparisons between obese participants with BED and obese 
participants without BED, therefore the results of this comparison have to be interpreted with 
caution. The reported studies used complex analytic approaches and were usually comprised of 
different procedures. For this reason, we were not able to describe in detail all the analyses and 
the results for each study, but we discussed those that were pertinent to the questions this 
review attempted to answer. 
 
5.0 CONCLUSIONS AND FUTURE DIRECTIONS 
In conclusion, we found sufficient evidence to support the presence of inhibitory control 
deficits in obese participants compared to controls. No significant differences in inhibitory 
control were found in obese participants with BED compared to obese participants without 
BED. Impairments in inhibitory control assessed with standardized neurocognitive tests appear 
thus to be associated with obesity independently from binge eating. Neuroimaging studies 
suggest that reduced function in an inhibitory network that has the PFC as the key region is 
related to current overweight and obesity and future weight gain.  
Future behavioral and neuroimaging studies should include a group of obese participants 
without BED and a group of obese participants with BED in order to distinguish the 
neurocognitive features of obesity from those of binge eating. Future longitudinal studies 
should also test the relationship between inhibitory control and PFC activity in response to 
interventions, in order to define predictors of outcome and provide differential indications for 
treatment (i.e. individual indications for nutritional counselling, psychosocial interventions, 
drug treatment, lifestyle change or combinations of these components). Knowing how 
inhibitory control affects response to treatment would allow to tailor the components of 
treatment interventions to the needs of the individual patient, as current emphasis on precision 
medicine mandates (Ashley, 2015). In light of the prominent role of PFC in inhibitory control 
and the alterations described, neuromodulation of the PFC  holds promise as a targeted 
approach to improve inhibitory control as part of a comprehensive treatment strategy for the 
treatment of obesity (Alonso-Alonso, 2013; Cosmo et al., 2015).  
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 "Figure 1. Flowchart illustrating the number of records identified and those included and excluded at 
each stage of the search." 
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Records identified through database searching and 
hand searching 
N =1793 
Records after duplicates removed 
N =1355 
Records screened 
N =1355 
Records excluded 
N =1265 
Full text articles accessed for 
eligibility 
N =90 
Studies included in 
quantitative 
synthesis  
(SST Adults) 
N =8 
Studies included 
in qualitative 
synthesis 
  
N =22 
(Adults=12; 
Children=10) 
Full text articles excluded 
with reasons 
N =53 
-inappropriate design (e.g. 
longitudinal, interventional 
study, no group 
differences):22 
-reviews, commentaries, 
editorials:12 
-wrong sample:13 
-no neurocognitive 
measures of inhibitory 
control: 6 
Neuroimaging 
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N =7 
  
Figure 2 Forest plot for the summary effect size of the difference in the stop 
signal reaction time (SSRT) between obese subjects and controls 
  
  
Figure 3 Forest plot for the summary effect size of the difference in the stop 
signal reaction time (SSRT) between obese subjects with BED and obese subjects 
without BED 
  
  
Figure 4 Schematic representation of brain areas where inhibitory control-
related activity correlates with baseline (red squares) or future (blue squares) 
BMI (based on Batterink et al., 2010; Hendrick et al., 2012 and Batterink et al., 
2010; Kishinevsky et al., 2012; Weygandt et al., 2015, 2013) 
 
 Table 1 Behavioral inhibition tasks in obese adults 
Paper Task Subjects OB/
NW 
OB-
BED/OB 
Outcom
e 
Results   
 
Quality 
score  
(x/8) 
Nederkoorn 
et al. 2006 
m-a 
Standard 
SST, delay 
discounting 
31 OB; 
28 NW  
F 
X  SSRT OB>NW in the 
last blocks of 
the SST (no 
significance 
difference 
considering the 
task in its 
entirety). Delay 
discounting 
task: OB=NW 
4 
Weller et al. 
2008 
Delay 
discounting 
task 
45 OB, 
50 NW 
F 
X  Delay 
discounti
ng 
Obese women 
showed greater 
delay 
discounting 
than control 
women. No 
difference was 
found in men 
 
 
6 
Duchesne et 
al. 2010 
Stroop OB-BED 
38, OB 
38 
M<F 
 X Errors, 
response 
times 
 OB-BED=OB 
 
 
6 
Davis et al. 
2010 
Delay 
discounting 
task 
65 OB-
BED; 73 
OB; 71 
NW 
F 
X X Indiffere
nce point 
NW>OB-BED; 
NW>OB 
OB= OB-BED 
 
 
5 
Nijs et al. 
2010 
Food-
related 
20 OB, 
20 NW 
X  Reaction 
times 
Reaction times 
for food stimuli 
5 
Stroop, 
EEG 
M<F were longer 
than for non-
food for all 
subjects;  
OB=NW 
Cohen et al. 
2011 
Stroop 42 OB, 
107 NW 
M, F 
X  Stroop 
color-
word 
trial; 
Stroop 
interfere
nce score 
The number of 
words 
completed in 
the color-word 
trial was lower 
in the obesity 
group; the 
Stroop 
interference 
was higher in 
the OB group 
 
7 
Mobbs et al. 
2011 
Food-body 
mental 
flexibility 
task 
(a food-
specific 
go/no-go) 
16 OB-
BED, 16 
OB, 16 
NW 
M<F 
X X N of 
errors 
OB-BED>NW; 
OB>NW; OB-
BED>OB 
 
 
5 
Galioto et 
al. 2012 
Stroop 41 OB-
BED, 90 
OB 
M, F 
 X Number 
of words 
correctly 
identified 
 OB-BED=OB 5 
Loeber et al. 
2012 
Food-
specific 
Go/no go 
task 
20 OB, 
20 NW 
M, F 
X  Response 
times 
All participants 
faster in 
responding to 
food compared 
to objects. No 
effects of 
category (food 
or object word), 
no effect of 
group, no 
categoryXgroup 
interaction 
5 
Hendrick et Standard 18 NW, X  SSRT NW=OB 3 
al. 2012  
m-a 
SST 13 OB  
F 
Fagundo et 
al. 2012 
SCWT 52 OB, 
137 NW 
F 
X  Stroop 
interfere
nce score 
OB<NW (OB 
have a worse 
performance) 
8 
Wu et al. 
2013 
m-a 
Standard 
SST, GDT 
19 BN, 
54 OB-
BED, 54 
OB 
M<F 
 X SSRT   OB-BED=OB 7 
Svaldi et al. 
2014 
m-a 
Food-
specific SST 
31 OB-
BED, 29 
OB 
F 
 X SSRT, 
errors 
OB-BED>OB in 
both SSRT and 
errors 
7 
Calvo et al. 
2014 
Go/no-go 32 NW, 
30 OB 
M, F 
X  Response 
time 
OB>NW 4 
Mole et al. 
2014 
m-a 
Standard 
SST, delay 
discounting 
task 
30 OB-
BED; 30 
OB, 30 
NW 
M, F 
X X SST: SSRT 
 
delay 
discounti
ng task: 
slope of 
the 
discounti
ng curve 
(k) 
Delay 
discounting 
OB-BED>NW; 
OB>NW 
 
 
6 
SSRT 
OB>NW; 
 
 
 
OB-BED<OB  
 
(=OB more 
impaired) 
OB-BED=NW 
 
 
Grant et al. 
2015 
m-a 
Standard 
SST 
NW 136; 
OW 49; 
OB 22 
M, F 
X  SSRT OB>NW  7 
Bongers et 
al. 2015 
m-a 
Standard 
SST, delay 
discounting 
task,  
185 OB; 
134 NW 
M<F 
X  SSRT Both in SST  and 
in delay 
discounting: OB 
= NW 
6  
Manasse et 
al. 2015 
SCWT (D-
KEFS); 
Delay 
discounting 
task 
31 OB-
BED; 43 
OB 
F 
 X Inhibition 
time; 
level of 
discounti
ng 
Delay 
discounting: 
OB-BED<OB 
(steeper 
discounting in 
OB-BED) 
 
5 
SCWT: 
OB-BED>OB 
 
 
Chamberlain 
et al. 2015  
m-a 
Standard 
SST 
346 NW; 
55 OB 
M, F 
X  SSRT OB>NW 6 
Hume et al. 
2015 
Food-
specific 
Stroop 
41 NW, 
19 OB 
F 
X  Reaction 
times, 
errors 
NW=OB  4 
 
BN: bulimia nervosa; OB: Obese subjects; OB-BED: Obese subjects with Binge Eating Disorder; CN: 
Normal weight controls; SCWT: Stroop color-word test; D-KEFS: Delis-Kaplan Executive Functioning 
System; M=males, F=females; M<F=predominantly female sample; m-a: included in the meta-analysis. 
 
  
 Table 2 Behavioral inhibition tasks in obese children  
Paper Task Subjects Age 
(years) 
Results  Quality 
score  
(x/8) 
Nederkoorn 
et al. 2006 
SST 15 OB-BED, 
15 OB, 31 
NW 
12-15 SSRT:  
(OB-BED + OB)>NW  
5 
Verbecken 
et al. 2009 
SST 41 OB, 40 
NW 
10-14 SSRT:  
OB >NW  
7 
Verdejo-
Garcia et al. 
2010  
Stroop, 
delay 
discounting 
27 OW; 34 
NW  
 
13-16 Stroop interference: 
OW>NW  (P=0.07) 
Delay discounting: 
OW=NW 
7 
Maayan et 
al. 2011 
SCWT  54 OB; 37 
NW 
16-19 Stroop interference 
score:  
OB<NW  
5 
Fields et al. 
2011 
Delay 
discounting 
task 
16 OB, 20 
NW 
(smokers) 
13-19 Delay Discounting:  
OB>NW  
4 
Kamijo et al. 
2012 
Go/no go 
EEG 
53 OB; 37 
NW  
 
7-9 No Go response 
accuracy:  
OB<NW  
5 
Nederkoorn 
et al. 2012 
SST 14OW; 
75NW 
7-9 SSRT:  
OW>NW  
6 
Fields et al. 
2013  
Delay 
discounting 
task, 
go/stop 
task  
21 OB; 20 
OW; 20 NW 
 
14-16 Delay discounting: 
OB>NW, OW>NW; 
SSRT: 
NW=OW=OB 
7 
Kulendran 
et al. 2014 
SST 53 OB; 50 
NW  
10-17 SSRT:  
OB>NW  
6 
 Reyes et al. 
2015 
Stroop, 
Go/no go 
93 OB; 92 
NW 
10 Stroop test reaction 
time:  
OB>NW;  
Go/no go variability: 
OB>NW  
6 
OB: Obese subjects; OW: overweight subjects; NW: Normal weight subjects; SCWT: stroop color-word 
test; SST=stop signal task; SSRT=stop signal reaction time. All the samples were comprised by both males 
and females. 
 
  
 Table 3 Brain imaging (fMRI and MEG) Inhibition studies and BMI  
Paper Aim Task Subjects Results 
Batterink et al. 
2010 
correlations 
between 
inhibitory 
control-
related 
brain 
activity and 
1. Current 
BMI; 2. BMI 
Change in 
time 
Food-
specific 
go/no-go 
task 
39 adolescent 
girls ranging 
from lean to 
obese.  
Adolescents with 
higher BMI showed a 
higher rate of 
commission errors 
and reduced 
activation of frontal 
inhibitory regions 
(SFG, MFG, VLPFC, 
mPFC, OFC)  
Kishinevski et 
al. 2012 
correlations 
between 
inhibitory 
control-
related 
brain 
activity and 
BMI change 
in time 
General 
delay 
discounting 
24 obese 
women 
 
More difficult 
compared to easier 
DD trials activated 
frontal areas (MFG, 
IFG, mPFC); also, less 
activation in these 
areas in difficult VS 
easy DD trials 
predicted a greater 
rate of weight gain 
over the subsequent 
1.3-2.9 years 
Hendrick et al. 
2012  
group 
differences 
between 
OB and CN 
and 
between 
BED-OB 
and OB; 
Testing 
correlations 
between 
inhibitory 
control-
related 
brain 
activity and 
SST 18 lean women, 
13 obese 
women 
No statistical 
differences in 
performance 
measures. During the 
task lean women had 
greater activation in 
insula, inferior 
parietal cortex, 
cuneus, 
supplementary 
motor area in stop as 
compared to go 
trials. Brain 
activations in these 
regions inversely 
correlate with BMI 
BMI across subjects 
Balodis et al. 
2013 
group 
differences 
between 
OB and CN 
SWCT 12 obese BED 
subjects; 13 
non-BED obese; 
11 CN 
 
BED subjects showed 
diminished activity in 
VMPFC, IFG, insula. 
Dietary restraint 
correlates negatively 
with right IFG and 
VMPFC activation in 
BED subjects but not 
in obese or CN 
Weygandt et 
al. 2013 
Testing 
correlations 
between 
inhibitory 
control-
related 
brain 
activity and 
BMI change 
in time 
Food delay 
discounting 
16 female 
subjects obese 
or overweight 
(BMI>27) and 
with 
overweight-
related 
comorbidities 
 
Higher behavioral 
impulse control was 
correlated with 
amount of weight 
loss after a 12 week 
diet. Brain activity 
before the diet in 
VMPFC and DLPFC 
correlated with 
subsequent weight 
loss. Stronger 
connectivity between 
these regions is 
associated to better 
dietary success and 
impulse control  
Hege et al. 
2015 
group 
differences 
between 
BED-OB 
and OB 
Food-
specific 
go/no-go 
18 BED obese 
women; 19 
obese non-BED 
Lower inhibition 
performance in BED; 
hypoactivity of the 
frontal control 
network during the 
inhibitory task 
Weygandt et 
al. 2015 
Testing 
correlations 
between 
inhibitory 
control-
related 
brain 
activity and 
BMI change 
in time 
Food delay 
discounting 
23 obese 
females. 
Method: DDT at 
beginning of 
diet, end, and 1 
year follow-up 
 
Behavioral measures 
of control and DLPFC 
activity at T0 
correlates with the 
degree of success in 
weight maintenance 
after 1 year. Neural 
signals correlate 
better with 
outcomes.  
 
SCWT: Stroop color-word test; SST=stop signal task; DDT= delay discounting 
task; BMI=body mass index; SFG=superior frontal gyrus; MFG=middle frontal 
gyrus; VLPFC=ventro-lateral prefrontal cortex; mPFC=medial prefrontal 
cortex; OFC=orbitofrontal cortex; VMPFC=ventromedial prefrontal cortex; 
DLPFC=dorsolateral prefrontal cortex; DD=delay discounting. All the studies 
used fMRI except Hege et al. 2015 which used magnetoencephalography 
(MEG). 
 
 
 
